StockData
Alector, Inc. logo

Alector, Inc. (ALEC) stock

ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$2.56−0.01 (-0.39%)

Close on Nov 17, 2026Market cap $285.84MP/E –Yield –

Alector operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Alector's operating cash flow for the twelve months ending Jun 30, 2026 was -$158.23M. For fiscal 2025 it was -$184.03M. The highest annual figure on record is $298.55M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$184.03M–
FY2024Dec 31, 2024-$229.91M–
FY2023Dec 31, 2023-$184.16M–
FY2022Dec 31, 2022-$20.33M-106.8%
FY2021Dec 31, 2021$298.55M–
FY2020Dec 31, 2020-$166.73M–
FY2019Dec 31, 2019-$99.31M-177.9%
FY2018Dec 31, 2018$127.46M–
FY2017Dec 31, 2017-$17.77M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$34.22M–
Q1 FY2026Mar 31, 2026-$49.81M–
Q4 FY2025Dec 31, 2025-$41.69M–
Q3 FY2025Sep 30, 2025-$32.51M–
Q2 FY2025Jun 30, 2025-$49.05M–
Q1 FY2025Mar 31, 2025-$60.78M–
Q4 FY2024Dec 31, 2024-$55.03M–
Q3 FY2024Sep 30, 2024-$50.73M–
Q2 FY2024Jun 30, 2024-$62.80M–
Q1 FY2024Mar 31, 2024-$61.35M–
Q4 FY2023Dec 31, 2023-$46.07M–
Q3 FY2023Sep 30, 2023-$46.54M–
Q2 FY2023Jun 30, 2023-$43.00M–
Q1 FY2023Mar 31, 2023-$48.55M-135.9%
Q4 FY2022Dec 31, 2022-$48.93M–
Q3 FY2022Sep 30, 2022-$49.05M-111.0%
Q2 FY2022Jun 30, 2022-$57.44M–
Q1 FY2022Mar 31, 2022$135.09M–
Q4 FY2021Dec 31, 2021-$49.27M–
Q3 FY2021Sep 30, 2021$445.05M–
Q2 FY2021Jun 30, 2021-$44.54M–
Q1 FY2021Mar 31, 2021-$52.69M–
Q4 FY2020Dec 31, 2020-$47.66M–
Q3 FY2020Sep 30, 2020-$40.82M–
Q2 FY2020Jun 30, 2020-$45.94M–
Q1 FY2020Mar 31, 2020-$32.31M–
Q4 FY2019Dec 31, 2019-$28.83M–
Q3 FY2019Sep 30, 2019-$28.86M–
Q2 FY2019Jun 30, 2019-$18.05M–
Q1 FY2019Mar 31, 2019-$23.57M-112.8%
Q4 FY2018Dec 31, 2018-$17.65M–
Q3 FY2018Sep 30, 2018-$22.36M–
Q2 FY2018Jun 30, 2018-$17.05M–
Q1 FY2018Mar 31, 2018$184.53M–

More Alector figures

See a number that looks wrong?